Top Story

TOPCAT: Spironolactone effectiveness differed by region

November 24, 2014

CHICAGO — The TOPCAT trial to show benefits for spironolactone in patients with HF with preserved ejection fraction was neutral overall, but the effectiveness of the drug varied by region, according to results of a post-hoc analysis.

Among those studied, patients from the United States, Argentina, Brazil and Canada showed a better response to spironolactone compared with patients from the Republic of Georgia and Russia, Marc A. Pfeffer, MD, PhD, FACEP, FAHA, the Dzau professor of medicine at Harvard University Medical School and the cardiovascular division of Brigham & Women’s Hospital, said at the American Heart Association Scientific Sessions.

In the Journals

Rehospitalization common for survivors of in-hospital cardiac arrest

November 23, 2014
Patients who have survived an in-hospital cardiac arrest have high rates of hospital readmission, according to recent results.These readmission rates, along with…
C. Michael Gibson

Novel apolipoprotein A-I formulation studied in AEGIS-I

November 22, 2014
A new phase 2b trial will assess a novel apolipoprotein A-I formulation and its effect on markers of reverse cholesterol transport and the stabilization of…
In the Journals

EPA with statins may reduce periprocedural MI in PCI

November 21, 2014
Patients receiving eicosapentaenoic acid with statins before PCI experienced reduced type IVa MI compared with those receiving statins only, recent findings…
In the Journals

CDC: Overall heart disease death rate fell, increased in certain subtypes

November 21, 2014
In a letter published in JAMA, researchers from the CDC reported that mortality rates for heart disease overall have declined, but increases were seen in certain…
More News Headlines »
Managing Acute Ischemic Stroke in the Emergency Department: Two Decades of Progress

Managing Acute Ischemic Stroke in the Emergency Department: Two Decades of Progress

This activity is supported by an educational grant from Genentech.

According to the American Heart Association Heart Disease and Stroke Statistics 2013 Update, approximately 795,000…
More »
Meeting News Coverage Video
Healio AHA2014 Zile th

New data may yield a 'change in the paradigm' of HF therapy

November 18, 2014
CHICAGO — Further analyses of the PARADIGM-HF trial provide more information on the efficacy of an…
More »
Controversial Issues and Challenging Cases

Controversial Issues and Challenging Cases in the New Frontier of Obesity Online Activity

This activity is supported by an educational grant from Eisai Inc.

Obesity has become a world-wide issue of utmost importance as its incidence and prevalence are associated with dramatic…
More »